CardioNavix
CardioNavix (dba CDL Nuclear Technologies) provides end-to-end cardiac PET and SPECT imaging solutions, including custom-built PET/CT suites, mobile rubidium generators, and mobile PET/CT units, to independent cardiology practices and hospitals across the United States.
- Company typePrivate
- Founded2016
- HeadquartersCranberry Township, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CardioNavix does
CardioNavix, doing business as CDL Nuclear Technologies, is a US-based privately held healthcare services company founded in 2016 and headquartered in Cranberry Township, Pennsylvania. The firm provides end-to-end cardiac imaging solutions centered on Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), serving independent cardiology practices and hospital cardiology departments that lack the capital or scale to operate in-house nuclear imaging infrastructure. Its portfolio spans four core offerings: Custom Cardiac PET/CT Suite Solutions (permanent purpose-built imaging suites installed at client sites), Daily Use Mobile Rubidium for Cardiac PET (on-demand radiotracer production delivered to sites), Mobile Cardiac PET/CT Solutions (fully equipped mobile imaging units), and SPECT Solutions.
The company's underlying technology combines capital-intensive imaging hardware (PET/CT scanners, SPECT systems) with radiotracer logistics, including daily mobile rubidium generator delivery, an operational model that allows CardioNavix to amortize production infrastructure across multiple customer sites. It goes to market via enterprise field sales directed at healthcare facilities, with a Contact page routing prospects to specialists for tailored solution design, supported by a client portal, newsletter, and industry events. Pricing is customized per engagement and not publicly disclosed, consistent with a managed services revenue model in which revenue derives from equipment installation, ongoing service contracts, and per-procedure or subscription arrangements with cardiology practices and hospital systems.
CardioNavix firmographics
Firmographics- Name
- CardioNavix
- Legal name
- CDL Nuclear Technologies
- Website
- https://cardionavix.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CardioNavix (dba CDL Nuclear Technologies) provides end-to-end cardiac PET and SPECT imaging solutions, including custom-built PET/CT suites, mobile rubidium generators, and mobile PET/CT units, to independent cardiology practices and hospitals across the United States.
- Ownership category
- akta.pro rank
CardioNavix industry classification
Industry- Product category
- Cardiac Imaging Services
- NAICS
- Diagnostic Imaging Centers (621512), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)
Keywords
Where CardioNavix is headquartered
LocationHeadquarters
- HQ city
- Cranberry Township
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CardioNavix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Cardiac Imaging Services: Provides end-to-end cardiac PET and SPECT imaging solutions to healthcare facilities and independent cardiology practices, likely through service contracts and equipment/solution provision arrangements.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
CardioNavix product offering
Product offeringCore offering
CardioNavix (doing business as CDL Nuclear Technologies) provides end-to-end cardiac PET and SPECT imaging solutions to healthcare facilities. Its offerings include custom-built cardiac PET/CT imaging suites, daily-use mobile rubidium-82 generators for cardiac PET, mobile cardiac PET/CT units, and SPECT imaging solutions, delivered as managed services to independent cardiology practices and hospitals.
Product overview
CDL Nuclear Technologies provides end-to-end Cardiac PET and SPECT imaging solutions for independent cardiology practices and hospitals. The product portfolio consists of four core offerings: Custom Cardiac PET/CT Suite Solutions (permanent custom-built imaging suites), Daily Use Mobile Rubidium for Cardiac PET Solutions (on-demand mobile rubidium generators), Mobile Cardiac PET/CT Solutions (fully equipped mobile PET/CT units), and SPECT Solutions (single photon emission computed tomography systems). Together, these solutions deliver comprehensive cardiac imaging services, combining state-of-the-art technology with experienced healthcare professionals to help physicians diagnose and manage cardiac disease with greater accuracy and precision.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Cardiac PET/CT Suite Solutions Custom-built cardiac PET/CT imaging suites designed for independent and hospital cardiology practices, providing state-of-the-art cardiac imaging technology for precise diagnosis and management of cardiac disease.
- Daily Use Mobile Rubidium for Cardiac PET Solutions Daily use mobile rubidium generator systems for cardiac PET imaging that provide on-demand radiotracer production for cardiac PET procedures, enabling flexible and accessible cardiac imaging services.
- Mobile Cardiac PET/CT Solutions Mobile cardiac PET/CT imaging solutions that bring advanced cardiac imaging capabilities directly to healthcare facilities, providing flexibility for practices without permanent imaging infrastructure.
- SPECT Solutions Single Photon Emission Computed Tomography (SPECT) solutions for cardiac imaging, providing nuclear medicine imaging capabilities for comprehensive cardiac diagnostics and disease management.
Quantifiable outcome
- Greater accuracy and precision in cardiac disease diagnosis and management
Companies that use CardioNavix
Customer profileSegments2 records
Ideal customer profiles2 records
CardioNavix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
CardioNavix partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
CardioNavix competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE HealthCare is one of the largest manufacturers of PET/CT and SPECT systems globally, with broad cardiology imaging capabilities and a large installed base. It competes with CDL Nuclear across both equipment supply and potential expansion into managed cardiac imaging services.
- Siemens Healthineers: Siemens Healthineers is a major manufacturer of PET/CT scanners and a broad imaging OEM with a global service footprint. CDL Nuclear's custom PET/CT suite offerings are built around equipment from this category of vendor, and Siemens is a structural competitor in the cardiac PET imaging value chain.
- Philips: Philips is a broad incumbent in diagnostic imaging, including PET/CT and SPECT systems used in cardiology. As a global imaging OEM with extensive service and solutions capabilities, Philips represents a large-scale comparable operating in the same cardiac imaging category as CDL Nuclear.
Direct peers
- Digirad: Digirad historically provided mobile nuclear medicine imaging services, including cardiac SPECT, to hospitals and physician offices. Its service-led, mobile-deployment model closely parallels CDL Nuclear's managed cardiac imaging services across independent and hospital-based cardiology customers.
- DMS Health Technologies: DMS Health Technologies supplies and operates mobile diagnostic imaging systems (MRI, CT, PET, nuclear medicine) for healthcare providers nationwide. Its asset-heavy mobile imaging deployment model and hospital/physician customer base closely mirror CDL Nuclear's mobile PET/CT and custom suite offering.
- Insight Health: Insight Health provides mobile diagnostic imaging services — including CT, MRI, and nuclear medicine — to hospitals and outpatient providers on a contract basis. Its mobile imaging-as-a-service model and healthcare facility customer base are directly comparable to CDL Nuclear's mobile cardiac PET/CT and SPECT services.
- Shared Imaging: Shared Imaging is a mobile imaging services provider that supplies, operates, and maintains diagnostic imaging equipment — including mobile CT, MRI, and nuclear medicine — on a contract basis. Its business model of mobile/managed imaging equipment deployment to hospitals is structurally similar to CDL Nuclear's mobile PET/CT and custom suite solutions.
- Lantheus Holdings: Lantheus is the leading manufacturer of rubidium-82 (Rb-82) generators (CardioGen-82) used in cardiac PET imaging. CDL Nuclear's 'Daily Use Mobile Rubidium' offering directly competes with or is built around Lantheus's generator franchise, making this the most directly comparable peer in the cardiac PET supply chain.
Others
- Bracco Imaging: Bracco Imaging is a global developer and supplier of diagnostic imaging agents, contrast media, and related devices, with strong adjacency to cardiac imaging workflows. While not a direct service competitor, Bracco is a relevant ecosystem peer in the broader cardiac imaging value chain that CDL Nuclear participates in.
Emerging players
- Curium: Curium is a global radiopharmaceutical company producing diagnostic and therapeutic isotopes, with overlap into cardiac PET tracers and SPECT agents. It is a relevant comparable in the radiopharma supply layer that underpins CDL Nuclear's mobile rubidium and cardiac PET offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CardioNavix social profiles
Digital presenceCardioNavix financial estimates
Financial estimateRevenue estimate
Valuation estimate
CardioNavix leadership team
Management profileNumber of profiles
CardioNavix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CardioNavix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CardioNavix
What does CardioNavix do?
CardioNavix (doing business as CDL Nuclear Technologies) provides end-to-end cardiac PET and SPECT imaging solutions to healthcare facilities. Its offerings include custom-built cardiac PET/CT imaging suites, daily-use mobile rubidium-82 generators for cardiac PET, mobile cardiac PET/CT units, and SPECT imaging solutions, delivered as managed services to independent cardiology practices and hospitals.
Is CardioNavix a public or private company?
CardioNavix is a private company. It is classified as unknown and is currently operating.
When was CardioNavix founded?
CardioNavix was founded in 2016. It employs 11 to 50 people.
Where is CardioNavix based?
CardioNavix is headquartered in Cranberry Township, United States, in the North America region.
How does CardioNavix make money?
One revenue line is on record: cardiac Imaging Services.
Who are CardioNavix's main competitors?
Broad incumbents on record are GE HealthCare, Siemens Healthineers and Philips. Direct peers are Digirad, DMS Health Technologies, Insight Health, Shared Imaging and Lantheus Holdings. Bracco Imaging is listed as an others. Curium is listed as an emerging player.
Does CardioNavix have an API?
No public API is recorded for CardioNavix.
What industry is CardioNavix in?
CardioNavix's product category is Cardiac Imaging Services. Its primary akta.pro industry code is HLAKABAE, Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear). Its NAICS code is 621512 and its SIC code is 3845.